A platinum‐based covalent viability reagent for single‐cell mass cytometry
Open Access
- 10 May 2012
- journal article
- research article
- Published by Wiley in Cytometry Part A
- Vol. 81A (6) , 467-475
Abstract
In fluorescence‐based flow cytometry, cellular viability is determined with membrane‐impermeable fluorescent reagents that specifically enter and label plasma membrane‐compromised nonviable cells. A recent technological advance in flow cytometry uses antibodies conjugated to elemental metal isotopes, rather than to fluorophores, to allow signal detection by atomic mass spectrometry. Unhampered by the limitations of overlapping emission fluorescence, mass cytometry increases the number of parameters that can be measured in single cells. However, mass cytometry is unable to take advantage of current fluorescent viability dyes. An alternative methodology was therefore developed here in which the platinum‐containing chemotherapy drug cisplatin was used to resolve live and dead cells by mass cytometry. In a 1‐min incubation step, cisplatin preferentially labeled nonviable cells from both adherent and suspension cultures, resulting in a platinum signal quantifiable by mass cytometry. This protocol was compatible with established sample processing steps for intracellular cytometry. Furthermore, the live/dead ratios were comparable between mass‐ and fluorescence‐based cytometry. Importantly, although cisplatin is a known DNA‐damaging agent, a 1‐min “pulse” of cisplatin did not induce observable DNA damage or apoptotic responses even within 6‐h post‐exposure. Cisplatin can therefore be used as a viability reagent for a wide range of mass cytometry protocols. © 2012 International Society for Advancement of CytometryKeywords
This publication has 26 references indexed in Scilit:
- Association of Reactive Oxygen Species-Mediated Signal Transduction with In Vitro Apoptosis Sensitivity in Chronic Lymphocytic Leukemia B CellsPLOS ONE, 2011
- Highly multiparametric analysis by mass cytometryJournal of Immunological Methods, 2010
- Dynamic Single-Cell Network Profiles in Acute Myelogenous Leukemia Are Associated with Patient Response to Standard Induction TherapyClinical Cancer Research, 2010
- Study of Cell Antigens and Intracellular DNA by Identification of Element-Containing Labels and Metallointercalators Using Inductively Coupled Plasma Mass SpectrometryAnalytical Chemistry, 2008
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross‐linking agent cisplatinCytometry Part A, 2004
- Chapter 15 Simultaneous Measurement of Cell Cycle and Apoptotic Cell Death1998
- Trypan Blue Exclusion Test of Cell ViabilityCurrent Protocols in Immunology, 1997
- A New Method for the Cytofluorometric Analysis of Mitochondrial Membrane Potential Using the J-Aggregate Forming Lipophilic Cation 5,5′,6,6′-Tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine Iodide (JC-1)Biochemical and Biophysical Research Communications, 1993
- Dead cell discrimination with 7‐amino‐actinomcin D in combination with dual color immunofluorescence in single laser flow cytometryCytometry, 1992